Top 10 Companies in Latin America In Vitro Diagnostics Market
Added: (Mon Dec 11 2023)
Pressbox (Press Release) -
The Latin America In Vitro Diagnostics (IVD) Market, projecting a CAGR of 5.5% during the forecast period. The market is expected to burgeon from $4.44 billion in 2023 to $6.45 billion by 2030. The Latin America IVD market encompasses consumables such as kits & reagents, instruments, software, and services. Driving this expansion are factors including the escalating prevalence of communicable and non-communicable diseases, a rise in medical tourism, a shift towards decentralized testing, and increased awareness concerning early disease diagnosis.
Top 10 Companies Contributing to the Latin America In Vitro Diagnostics Market:- https://meticulousblog.org/top-10-companies-in-latin-america-in-vitro-diagnostics-ivd-market/
Hoffmann-La Roche Ltd. (Switzerland) - Engaged in enhancing healthcare standards through medicines, offering a diverse range of diagnostics, including centralized and point-of-care kits & reagents.
Abbott Laboratories (U.S.) - A global company discovering, developing, and marketing a comprehensive array of healthcare products, prominently active in diagnostics through segments like Core Laboratory and Molecular Diagnostics.
Danaher Corporation (U.S.) - Designs, manufactures, and markets products & services across various sectors, offering diagnostics solutions in clinical lab, critical care, and anatomical & pathological diagnostics.
Siemens Healthineers AG (Germany) - Developing and selling products with applications in medical imaging, laboratory diagnostics, and point-of-care testing, operating in the IVD market via molecular diagnostics and point-of-care diagnostics.
Becton, Dickinson and Company (U.S.) - A medical technology company specializing in diagnostic systems for infectious diseases, women's health, respiratory infections, and more, catering to hospitals, laboratories, clinics, and other healthcare settings.
bioMérieux SA (France) - Specializing in a wide range of diagnostic products & solutions for infectious diseases in clinical settings and microorganism detection in agri-food, pharmaceuticals, and cosmetics industries.
Thermo Fisher Scientific Inc. (U.S.) - Providing analytical instruments, laboratory equipment, and diagnostics instruments through its Specialty Diagnostics segment, with a broad global presence.
QIAGEN N.V. (Netherlands) - Offering molecular diagnostic technologies, automated systems, assays, markers, and reagents for cancer and infectious diseases, reaching over 500,000 customers worldwide.
Wama Diagnóstica (Brazil) - Researching, developing, and producing laboratory diagnostic kits & reagents, emphasizing immunodiagnostics and manufacturing immuno-chromatographic tests.
Wiener Laboratorios SAIC (Argentina) - Catering to clinical laboratories and blood banks with diagnostic products like clinical chemistry kits, hematology analyzers, and immunology assays.
Meticulous Research Insights and Report Highlights
Meticulous Research® presents a comprehensive report offering detailed insights into the recent financial performance, key products, significant company strategies, partnerships, and acquisitions for each of the listed companies. The report serves as an invaluable resource for understanding market trends, aiding informed decision-making across industries.
Download Free Sample Report :- https://www.meticulousresearch.com/download-sample-report/cp_id=5105
About Meticulous Research®
Meticulous Research® stands as a trailblazer in delivering precise, high-quality market intelligence, employing rigorous methodologies to offer accurate insights and advisories across various industries.
Key product insights
Strategic initiatives
Partnerships and acquisition
The report compiled by Meticulous Research® offers a detailed analysis of these companies, encompassing:
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research